AAHD and the Lakeshore Foundation have joined the ITEM (Independence Through Enhancement of Medicare and Medicaid) Coalition letter to Congress supporting HR 1691, a bill that would authorize a 4 year transitional payment of FDA approved “critical breakthrough products.” The December 12 ITEM Coalition letter is here: PDF.